Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports

  • 📰 SaltWire Network
  • ⏱ Reading Time:
  • 9 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 63%

Business News News

Business Business Latest News,Business Business Headlines

Explore stories from Atlantic Canada.

Seniors displaced after Yarmouth fire | SaltWire #fire #yarmouth #seniors #news -Merck & Co is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company Eyebiotech in an agreement that could see an additional $1.7 billion in milestone payments, the Wall Street Journal reported on Tuesday.

Eyebiotech is a clinical stage opthalmology company, with operations in the U.S. and the UK, that seeks to treat patients with sight-threatening diseases.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 45. in BUSÄ°NESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reportsExplore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »